Related Experiment Video
Updated: Apr 6, 2026
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
1Via Provinciale 27, 19030 Castelnuovo Magra, Italy. reliol@libero.it.
Abstract:
Manufactured tobacco contains over 4, 000 toxic substances, but only a few exert adverse cardiovascular effects. Nicotine and its metabolites, carbon monoxide, thiocyanate and some aromatic amines play a strong, although different, role to determine cardiovascular damage. Of these substances, however, nicotine, acting by the double mechanism of addiction and receptor-binding, and carbon monoxide by increasing the production of carboxyhemoglobin and hypoxia, are the main determinants of the damage. The development of the alterations of heart and blood vessels follows a typical way, initially consisting of functional responses that become irreversible pathological lesions at the time. Myocardium and endothelial cells are the targets where cigarette smoking exerts its effects. The first displays functional and pathological disorders primarily related to ischemic heart disease, cardiomyopathy, including experimental cardiomyopathy from smoking, and heart failure, while the second should be interpreted as a structure, which shows early alterations caused by smoking as clearly evident, repeatable and typically depending on smoking toxicity. Cardiovascular damage has a functional onset, which, at the time, leads to irreversible morphological damage of myocardial and endothelial cells.
Insights
Cigarette smoking damages the cardiovascular system through toxic substances like nicotine and carbon monoxide. These lead to functional changes that become irreversible heart and blood vessel damage.
Area of Science:
- Cardiovascular Science
- Toxicology
Background:
- Cigarette smoke contains over 4,000 toxic substances.
- A few key toxins significantly impact cardiovascular health.
Purpose of the Study:
- To identify the primary toxic substances in tobacco smoke responsible for cardiovascular damage.
- To elucidate the mechanisms and progression of smoking-induced cardiovascular alterations.
Main Methods:
- Review of existing literature on the cardiovascular effects of tobacco smoke components.
- Analysis of the roles of nicotine, carbon monoxide, and other toxins.
- Examination of the cellular targets (myocardium, endothelial cells) and lesion development.
Main Results:
- Nicotine (addiction, receptor-binding) and carbon monoxide (carboxyhemoglobin, hypoxia) are key determinants of cardiovascular damage.
- Smoking-induced cardiovascular damage progresses from functional changes to irreversible pathological lesions.
- Myocardium and endothelial cells are primary targets, leading to ischemic heart disease, cardiomyopathy, heart failure, and early vascular alterations.
Conclusions:
- Specific toxic components in cigarette smoke initiate a cascade of cardiovascular damage.
- The damage evolves from reversible functional responses to irreversible structural and pathological changes in the heart and blood vessels.
- Understanding these mechanisms is crucial for addressing smoking-related cardiovascular disease.
More Related Videos
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
10:47Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Related Concept Videos
01:26Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
01:26Coronary Artery Disease II: Pathophysiology
01:25Bioactivation and Tissue Toxicity
01:24Drug Toxicity: Dose-Dependent Reactions